Skip to content

    Women's Health

    Font Size
    A
    A
    A

    Panel Recommends HPV Test as Replacement for Pap

    Experts voted 13-0 that Roche's test was safe and effective as first step in cervical cancer screening

    WebMD News from HealthDay

    By Steven Reinberg

    HealthDay Reporter

    WEDNESDAY, March 12, 2014 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel voted unanimously on Wednesday that a new HPV test could be used before or instead of the Pap smear as a first step in cervical cancer screening.

    In three separate 13-0 votes, the agency's Medical Devices Advisory Committee Microbiology Panel concluded that the cobas HPV (human papillomavirus) test, made by Roche Molecular Systems, is safe and effective as a first-line screen for cervical cancer.

    Although the FDA is not required to follow the recommendations of its advisory panels, it typically does.

    HPV, a sexually transmitted virus, is thought to cause the majority of cervical cancers. Certain strains, such as HPV 16 and 18, are most strongly tied to these tumors. The virus also causes genital warts in both men and women and certain head and neck cancers.

    Roche was looking for the FDA to approve its HPV test as a first-line diagnostic tool. Women who test positive for the two high-risk HPV strains would then be asked to undergo colposcopy, which involves using a device that allows the doctor to get a clear view of the vulva, vagina and cervix and take a sample for further testing.

    In addition, women who did not have HPV 16 or 18 but had other high-risk types of the virus would then have a Pap test to see if a colposcopy was needed. The data the committee reviewed in its decision comes from a trial called ATHENA, which included more than 47,000 women.

    Testifying before the panel, Dr. David Chelmow, chair of the department of obstetrics and gynecology at Virginia Commonwealth University School of Medicine in Richmond, noted that "cervical cancer screening has been a huge success in decreasing cervical cancer incidence and death."

    Chelmow, representing the American College of Obstetricians and Gynecologists, added that "the college strongly supports further improving cervical cancer screening through the introduction of new paradigms such as HPV testing for primary screening. HPV testing as a primary screening method for cervical cancer is very promising, and appears effective for screening for cervical cancer."

    Today on WebMD

    hands on abdomen
    Test your knowledge.
    womans hand on abdomen
    Are you ready for baby?
     
    birth control pills
    Learn about your options.
    insomnia
    Is it menopause or something else?
     
    woman in bathtub
    Slideshow
    period
    VIDEO
     
    bp app on smartwatch and phone
    Slideshow
    estrogen gene
    Quiz
     

    Send yourself a link to download the app.

    Loading ...

    Please wait...

    This feature is temporarily unavailable. Please try again later.

    Thanks!

    Now check your email account on your mobile phone to download your new app.

    Blood pressure check
    Slideshow
    hot water bottle on stomach
    Quiz
     
    question
    Assessment
    Attractive young woman standing in front of mirror
    Quiz